Company intelligence / Profile preview

Perflow Medical

Netanya, Central District, Israelperflow.com ↗

Ownership: Private
Employees: ~129
Development stage: Commercial

Overview

Perflow Medical has developed and commercialized proprietary neurovascular devices for the treatment of acute ischemic stroke and intracranial aneurysms. Their products are CE Marked in Europe, with clinical use reported for their Stream and Cascade product lines. The company emphasizes real-time physician control during procedures to improve outcomes.

Therapeutic areas: CardiovascularNeurology
Modalities: Device (specifically neurovascular intervention devices)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Stream Dynamic Neuro-Thrombectomy Net

Commercial

Indications: Acute ischemic stroke

Beyond the preview

Go deeper on Perflow Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perflow Medical.

Explore the full profile